Latest News
Timely, factual reporting across artificial intelligence, cybersecurity, companies and markets, EU AI regulation, health and biotech, and climate and energy.
Lite News is a news feed and wire service for publishers and platforms. Below is a live sample of our continuously updated reporting. Learn more about accessing and reusing our reporting | Get News Feeds
-
Humyn Labs Announces $47 Million Series A
Humyn Labs plans to use the funds to expand physical-AI data operations and infrastructure in Brazil, India and South Korea.
-
11 EU States Request New AI Copyright Legislation
The request would cover Article 4’s text-and-data-mining exception, under which rights holders can reserve rights using machine-readable methods for online content.
-
Google Begins Gemini 4 Neon Rollout
Gemini 4 Neon supports inputs across video, audio, images and text, with a one-million-token context limit.
-
Ofgem Opens Consultation on AI Assurance Guidance
Responses are due by 15 January 2027; Ofgem plans to publish its decision and final guidance in March.
-
Anthropic Prices IPO at $83 Per Share
Anthropic expects trading to begin on Nasdaq on November 19 under the symbol ANT, with the offering’s anticipated closing the next day.
-
MHRA Secures Funding to Develop AdvanceGxP Service
AdvanceGxP will not yet accept applications; the MHRA is inviting organisations to register interest in pilot testing.
-
BSI Issues Java4Shell Alert and Calls for Updates
Sophos said the flaw requires attacker-supplied data to reach the decoder on x86-64 processors with AVX-512 VBMI support.
-
EU Reaches Provisional Deal on Energy Project Permits
Member states would have 18 months to incorporate the directive into national law once it is formally adopted.
-
FDA Grants Nelkarmi Accelerated Approval for Lung Cancer
The indication covers adults previously treated with alectinib alone or with platinum-based chemotherapy and at least two ALK inhibitors.
-
Isomorphic Labs Raises $5 Billion in Series C Funding
The planned work includes improving IsoDDE and building infrastructure for translational research and clinical development.